Pritesh Shah, Chief Commercial Officer at NovoCure Ltd (NVCR), sold 7,338 shares at $71.19 ($522K) on 2022-03-09, disclosed to the SEC on 2022-03-11.
Seasonal sale ($522k) by Chief Commercial Officer — this insider has traded NVCR in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $71.19 | 3,669 | $261K | 50.0% |
| 2 | $71.19 | 3,669 | $261K | 50.0% |
| Total | $71.19 avg | 7,338 | $522K | 100% |
| Filing → |
| NVCR | SELL | 2023-03-07 | $3.3M | — | Filing → |
| NVCR | SELL | 2023-03-06 | $141K | — | Filing → |
| NVCR | SELL | 2023-03-02 | $294K | — | Filing → |